The Innovation Gap: The Broader Impact of Metabolic Drugs on Related Diseases

Picasso Ballroom

Tuesday, September 24, 2024

11:20 AM - 12:00 PM

Moderator

Jason Zemansky, PhD

SMid-Cap Biotech Analyst, BofA Global Research

Panelists

Craig Basson, MD, PhD

Chief Medical Officer, Bitterroot Bio

Joshua Cohen

Co-CEO, Amylyx Pharmaceuticals

Punit Dhillon

CEO, Skye Bioscience

Justin Klee

Co-CEO, Amylyx Pharmaceuticals

Rohan Palekar

CEO, 89bio